DANA CULPEPPER: Open Payments
NPI 1699083501 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,426 in 68 payments from 15 companies in 2025. Trend: 2023 $1,738 · 2024 $1,546 · 2025 $1,426
Food & beverage: $1,326Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $300 |
| Janssen Biotech, Inc. | 10 | $246 |
| Novartis Pharmaceuticals Corporation | 7 | $144 |
| Regeneron Healthcare Solutions, Inc. | 4 | $101 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $101 |
| UCB, Inc. | 5 | $99 |
| LEO Pharma Inc. | 5 | $97 |
| Lilly USA, LLC | 4 | $82 |
| GENZYME CORPORATION | 3 | $57 |
| Incyte Corporation | 3 | $56 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, RINVOQ, Bimzelx, EBGLYSS, ANZUPGO, COSENTYX.
Industry payments across AL — which companies pay providers there.
